Perioperative concerns and management of pressurised intraperitoneal aerosolised chemotherapy: Report of two cases

Pressurised intraperitoneal aerosolised chemotherapy (PIPAC) is a new, mostly supportive approach to help patients with advanced peritoneal metastasis to increase the lifespan. It carries occupational hazards to health-care workers and especially anaesthesiologist during the procedure. The aerosolised chemotherapy can also cause chemical peritonitis and organ dysfunction in the perioperative period. In this case report, we present the report of two cases and discuss the perioperative concerns and management related to PIPAC.

[1]  C. Tempfer,et al.  Pressurized intraperitoneal aerosol chemotherapy (PIPAC) as a neoadjuvant therapy before cytoreductive surgery and hyperthermic intraperitoneal chemotherapy , 2016, World Journal of Surgical Oncology.

[2]  Martha Polovich Minimizing Occupational Exposure to Antineoplastic Agents , 2016, Journal of infusion nursing : the official publication of the Infusion Nurses Society.

[3]  W. Solass,et al.  Pressurized intraperitoneal aerosol chemotherapy with oxaliplatin in colorectal peritoneal metastasis , 2016, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

[4]  W. Solass,et al.  Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) with Low-Dose Cisplatin and Doxorubicin in Gastric Peritoneal Metastasis , 2015, Journal of Gastrointestinal Surgery.

[5]  W. Solass,et al.  Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC): Occupational Health and Safety Aspects , 2013, Annals of Surgical Oncology.

[6]  A. Macrì,et al.  Rationale and techniques of cytoreductive surgery and peritoneal chemohyperthermia. , 2011, World journal of gastrointestinal oncology.

[7]  R. Gill,et al.  Treatment of gastric cancer with peritoneal carcinomatosis by cytoreductive surgery and HIPEC: A systematic review of survival, mortality, and morbidity , 2011, Journal of surgical oncology.

[8]  D. Alderson,et al.  Systematic review of intraperitoneal chemotherapy for gastric cancer , 2011, The British journal of surgery.

[9]  Michael F. Flessner,et al.  Intraperitoneal therapy for peritoneal tumors: biophysics and clinical evidence , 2010, Nature Reviews Clinical Oncology.